$1.65 Billion is the total value of BRIDGER MANAGEMENT, LLC's 37 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 36.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LH | Sell | LABORATORY CORP AMER HLDGS | $99,415,000 | -1.6% | 614,622 | -2.9% | 6.03% | -9.5% |
ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $99,030,000 | +110.5% | 2,539,223 | -2.3% | 6.01% | +93.5% |
GDDY | Sell | GODADDY INCcl a | $91,945,000 | -10.2% | 1,496,992 | -26.5% | 5.58% | -17.5% |
MDCO | Sell | MEDICINES CO | $87,538,000 | +14.0% | 2,657,486 | -5.4% | 5.31% | +4.7% |
POST | Buy | POST HLDGS INC | $85,837,000 | +8.6% | 1,133,009 | +13.5% | 5.21% | -0.2% |
NKTR | Sell | NEKTAR THERAPEUTICS | $71,034,000 | -13.0% | 668,492 | -51.1% | 4.31% | -20.1% |
ZBH | Buy | ZIMMER BIOMET HLDGS INC | $70,075,000 | +518.2% | 642,652 | +584.2% | 4.25% | +468.2% |
HUM | Sell | HUMANA INC | $68,349,000 | -9.5% | 254,246 | -16.5% | 4.14% | -16.8% |
DXCM | Buy | DEXCOM INC | $66,567,000 | +36.3% | 897,620 | +5.5% | 4.04% | +25.3% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $65,461,000 | +3.0% | 549,632 | +9.9% | 3.97% | -5.4% |
ERI | Sell | ELDORADO RESORTS INC | $61,223,000 | -25.8% | 1,855,250 | -25.4% | 3.71% | -31.8% |
MS | Sell | MORGAN STANLEY | $58,105,000 | -8.5% | 1,076,809 | -11.0% | 3.52% | -15.9% |
MGM | MGM RESORTS INTERNATIONAL | $53,347,000 | +4.9% | 1,523,332 | 0.0% | 3.24% | -3.6% | |
INCY | INCYTE CORP | $51,844,000 | -12.0% | 622,152 | 0.0% | 3.14% | -19.2% | |
WMGI | Buy | WRIGHT MED GROUP N V | $50,220,000 | +11.9% | 2,531,245 | +25.2% | 3.05% | +2.8% |
WCG | Buy | WELLCARE HEALTH PLANS INC | $48,473,000 | +4.7% | 250,339 | +8.8% | 2.94% | -3.8% |
CHTR | Buy | CHARTER COMMUNICATIONS INC Ncl a | $43,714,000 | +12.1% | 140,460 | +21.0% | 2.65% | +3.0% |
AWI | Sell | ARMSTRONG WORLD INDS INC NEW | $43,330,000 | -18.2% | 769,622 | -12.0% | 2.63% | -24.8% |
VSAT | Buy | VIASAT INC | $37,525,000 | +4.6% | 570,979 | +19.1% | 2.28% | -3.9% |
HRTX | New | HERON THERAPEUTICS INC | $35,261,000 | – | 1,277,560 | +100.0% | 2.14% | – |
TPX | TEMPUR SEALY INTL INC | $34,160,000 | -27.8% | 754,258 | 0.0% | 2.07% | -33.6% | |
TGTX | Sell | TG THERAPEUTICS INC | $33,710,000 | -6.4% | 2,373,920 | -45.9% | 2.04% | -14.0% |
LBRDA | LIBERTY BROADBAND CORP | $33,097,000 | -0.3% | 390,292 | 0.0% | 2.01% | -8.4% | |
MSGN | New | MSG NETWORK INCcl a | $30,421,000 | – | 1,346,056 | +100.0% | 1.84% | – |
RCKT | New | ROCKET PHARMACEUTICALS INC | $29,598,000 | – | 1,578,569 | +100.0% | 1.80% | – |
SMG | New | SCOTTS MIRACLE GRO COcl a | $29,436,000 | – | 343,274 | +100.0% | 1.78% | – |
BAC | New | BANK AMER CORP | $28,264,000 | – | 942,436 | +100.0% | 1.71% | – |
FB | FACEBOOK INCcl a | $27,920,000 | -9.4% | 174,731 | 0.0% | 1.69% | -16.8% | |
WVE | Buy | WAVE LIFE SCIENCES LTD | $20,829,000 | +75.6% | 519,435 | +53.7% | 1.26% | +61.3% |
GDEN | New | GOLDEN ENTMT INC | $17,715,000 | – | 762,570 | +100.0% | 1.07% | – |
VRSN | VERISIGN INC | $15,823,000 | +3.6% | 133,456 | 0.0% | 0.96% | -4.8% | |
TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $12,818,000 | -9.8% | 750,000 | 0.0% | 0.78% | -17.2% | |
DRNA | Buy | DICERNA PHARMACEUTICALS INC | $11,728,000 | +43.4% | 1,226,820 | +35.4% | 0.71% | +31.7% |
PVG | PRETIUM RES INC | $10,998,000 | -41.6% | 1,651,328 | 0.0% | 0.67% | -46.4% | |
ALXN | New | ALEXION PHARMACEUTICALS INC | $10,263,000 | – | 92,074 | +100.0% | 0.62% | – |
ARMO | New | ARMO BIOSCIENCES INC | $8,683,000 | – | 232,115 | +100.0% | 0.53% | – |
DNLI | DENALI THERAPEUTICS INC | $5,053,000 | +3.4% | 312,500 | 0.0% | 0.31% | -5.3% | |
CMG | Exit | CHIPOTLE MEXICAN GRILL INC | $0 | – | -55,716 | -100.0% | -1.06% | – |
COG | Exit | CABOT OIL & GAS CORP | $0 | – | -919,090 | -100.0% | -1.74% | – |
EVHC | Exit | ENVISION HEALTHCARE CORP | $0 | – | -1,094,194 | -100.0% | -2.50% | – |
DVA | Exit | DAVITA INC | $0 | – | -724,416 | -100.0% | -3.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.